The Fracture Risk Assessment Tool predictions suggest patients who don’t meet guideline criteria for parathyroidectomy may ...

Emerging evidence suggests some sugar substitutes may affect metabolism, gut microbiome, and cardiovascular health more than ...

Semaglutide and tirzepatide use is rising among patients with rheumatic and musculoskeletal diseases and is linked to meaningful 1-year weight loss, especially in tirzepatide users.

The conditional authorization covers adults and children aged 2 years and older with severe or life-threatening ...

An early evaluation of 'Swap to Stop' scheme in England shows a 4-week quit rate of 34.3% among recipients of free ...

The FDA has approved datopotamab deruxtecan (Dato-DXd, Datroway, Daiichi Sankyo) for the treatment of patients with ...

Insomnia, sleepiness, fatigue, and stress were associated with higher depression scores, but caffeine appeared to lessen the ...

A cohort study of births in Brazil found increased hospitalization risk through age 3 after maternal chikungunya; results ...

The oral therapy is intended for adults with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis, two fibrotic ...

Novel CRISPR-Cas9 treatments are proving effective in reversing disease for life. But ensuring their long-term safety will ...

Dr Sunnie Kim previews key GI trials highlighting novel bispecific antibodies, dual immunotherapy combinations, KIT ...

NICE has recommended a new treatment option for adults with recurrent or metastatic cervical cancer that has progressed on or ...